How prevalent is cardiac amyloidosis and which patients should be screened?
- PMID: 36093633
- DOI: 10.1002/ejhf.2685
How prevalent is cardiac amyloidosis and which patients should be screened?
Comment on
-
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies.Eur J Heart Fail. 2022 Dec;24(12):2342-2351. doi: 10.1002/ejhf.2532. Epub 2022 May 16. Eur J Heart Fail. 2022. PMID: 35509173 Free PMC article.
References
-
- Ravichandran S, Lachmann HJ, Wechalekar AD. Epidemiologic and survival trends in amyloidosis, 1987-2019. N Engl J Med. 2020;382:1567-8.
-
- Aimo A, Merlo M, Porcari A, Georgiopoulos G, Pagura L, Vergaro G, et al. Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies. Eur J Heart Fail. 2022;24:2342-51.
-
- Nitsche C, Mascherbauer K, Calabretta R, Koschutnik M, Dona C, Dannenberg V, et al. Prevalence and outcomes of cardiac amyloidosis in all-comer referrals for bone scintigraphy. J Nucl Med. 2022. https://doi.org/10.2967/jnumed.122.264041
-
- Longhi S, Guidalotti PL, Quarta CC, Gagliardi C, Milandri A, Lorenzini M, et al. Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy. JACC Cardiovasc Imaging. 2014;7:531-2.
-
- Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med. 2008;40:232-9.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
